Semaglutide, branded as Rybelsus, Wegovy or Mounjaro, most popularly identified by Ozempic (as branded by Danish pharma giant ...

While the weight loss results were impressive across the group, the cost and side effects remain important barriers for ...

Eli Lilly plans to turn India into a growth market by addressing its diabetes and obesity challenges with its new treatment, ...

Eli Lilly is exploring partnerships with Indian pharma firms to market its anti-diabetes and weight loss drug Mounjaro, ...

Is the world ready for this?" he said. On March 20, Bloomberg reported that Eli Lilly is set to launch its first weight-loss drug, Mounjaro—the likely equivalent of the weight-loss drug Ozempic in ...

Eli Lilly's CEO David Ricks discusses the launch of diabetes and anti-obesity drugs Mounjaro and Zepbound, focusing on expanding access in emerging markets. He highlights new weight-loss drugs and ...

Unlike the US, Europe or other developed markets, Mounjaro will have to be purchased out-of-pocket in India, as obesity is ...

Trump hinted that the US will impose a 25%+ tariff on pharmaceuticals after giving US companies time to build more ...

Impact of Trump’s tariffs on IT companies’ demand outlook, why kirana share in FMCG declining decoded, inward remittance data ...

Mounjaro (Tirzepatide), a groundbreaking GLP-1 receptor agonist targeting GIP receptors, is now available in India for ...

Zerodha CEO Nithin Kamath highlighted the transformative potential of weight-loss drugs Ozempic and Mounjaro, which help in ...